|
DCAF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02309999974837E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89869997291714E-09 |
| Normal-vs-Stage2 |
7.960400E-02 |
| Normal-vs-Stage3 |
7.288200E-01 |
| Normal-vs-Stage4 |
2.900400E-01 |
| Stage1-vs-Stage2 |
2.079200E-01 |
| Stage1-vs-Stage3 |
2.008200E-02 |
| Stage1-vs-Stage4 |
3.153500E-04 |
| Stage2-vs-Stage3 |
3.173000E-01 |
| Stage2-vs-Stage4 |
4.672300E-02 |
| Stage3-vs-Stage4 |
3.161000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.06649999953979E-07 |
| Normal-vs-AfricanAmerican |
3.82519999997388E-06 |
| Normal-vs-Asian |
6.776200E-01 |
| Caucasian-vs-AfricanAmerican |
5.057000E-01 |
| Caucasian-vs-Asian |
2.670600E-01 |
| AfricanAmerican-vs-Asian |
2.285600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30370003681435E-09 |
| Normal-vs-Female |
2.200600E-01 |
| Male-vs-Female |
3.648500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.440500E-03 |
| Normal-vs-Extreme_Weight |
1.61580000046513E-07 |
| Normal-vs-Obese |
1.936240E-03 |
| Normal-vs-Extreme_Obese |
4.564800E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.738430E-01 |
| Normal_Weight-vs-Obese |
8.691800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.916750E-01 |
| Extreme_Weight-vs-Obese |
2.126600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.035000E-01 |
| Obese-vs-Extreme_Obese |
2.465800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.420000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.8080999999448E-06 |
| Normal-vs-Age(61-80Yrs) |
4.87250000347217E-08 |
| Normal-vs-Age(81-100Yrs) |
1.0797999999701E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.763600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.698100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.459400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.144400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.031610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.023200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85550463882578E-11 |
| Normal-VS-Type2 PRCC |
8.224400E-03 |
| Normal-VS-KIRP CIMP |
6.198300E-03 |
| Normal-VS-Unclassified PRCC |
1.349650E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.257500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.41700009901069E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
1.742160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.47940000000547E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.347200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.426600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.824620E-04 |
| Normal-vs-N1 |
1.691020E-01 |
| Normal-vs-N2 |
9.001800E-01 |
| N0-vs-N1 |
2.955300E-04 |
| N0-vs-N2 |
1.655790E-01 |
| N1-vs-N2 |
7.079800E-01 |
|
|
